The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
about
Complementary therapies for chronic plaque psoriasisInfliximab in the treatment of plaque type psoriasis.Emerging drugs for psoriasis.How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency.The economic burden of psoriasis: a systematic literature review.Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service.Economic burden of psoriatic patients in Japan: Analysis from a single outpatient clinic.Effects of briakinumab treatment for moderate to severe psoriasis on health-related quality of life and work productivity and activity impairment: results from a randomized phase III study.Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea.Number needed to treat and costs per responder among biologic treatments for moderate-to-severe plaque psoriasis in Japan.What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region.Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United StatesISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study
P2860
Q24194968-AA2F809B-DB3A-4970-A814-C0B7ABF88A87Q34620291-F62A8153-D28B-4CB4-811E-0106246E2D51Q36634244-AA87651D-2A85-41D9-86C9-19A55BF5D104Q36921945-E47356A9-4FC1-4773-9D30-1DAED868C0BFQ37303223-5CE324FA-00A1-48D7-81E9-CAEDA82E8357Q37669457-0EA4B9D4-AB95-4984-BB7D-B2A06A5C4D57Q37898704-277BB68F-B038-49ED-BE2F-10D385039334Q38232792-FF82F88A-1745-47D6-B250-62B3FAFC23CDQ38636664-1EE6AD60-2F72-4C01-B71D-614C8010303BQ38838614-95C80746-4A06-4709-8F88-ABCB0B9291BFQ44554932-97BAA9D5-D7EF-4B09-803D-04F344067200Q46152803-8DF00380-6978-4531-9040-EDD398D11B63Q48023865-24108D39-953C-447F-A061-0E6DEADFF970Q51112868-EB5E0752-B7D1-4B74-BE50-2D2959A6F042Q57995214-DCB7235E-F7B9-49B1-B9E4-110A14F60E15Q58404106-436188F6-684C-4CCB-BBDE-0EEEE8CEF0F5
P2860
The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The impact of biologics on the ...... e economics of psoriasis care.
@ast
The impact of biologics on the ...... e economics of psoriasis care.
@en
type
label
The impact of biologics on the ...... e economics of psoriasis care.
@ast
The impact of biologics on the ...... e economics of psoriasis care.
@en
prefLabel
The impact of biologics on the ...... e economics of psoriasis care.
@ast
The impact of biologics on the ...... e economics of psoriasis care.
@en
P1476
The impact of biologics on the ...... he economics of psoriasis care
@en
P2093
Daniel J Pearce
Kevin R Stein
P356
10.1016/J.SDER.2005.01.004
P577
2005-03-01T00:00:00Z